Karolinska Development’s Portfolio Company Anacardio Raises Sek 150 Million To Start Clinical Trial With Candidate Drug Ac01 In Heart Failure
Amount Raised
SEK150 Million
Round Type
Funding Round
StockholmSoftwareHealth CareDescription
STOCKHOLM, SWEDEN September 7, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed a series A investment round of SEK 150 million from a group of long-term and reputable investors, including Flerie Invest, Industrifonden and 3B Health Ventures. The successful financing means a clear external validation of the potential of the company’s drug candidate AC01, which will shortly be evaluated in a clinical phase 1b/2a study in patients with heart failure.
Quick answer
AnaCardio raised SEK150 Million in a Funding Round round, dated September 7, 2022. AnaCardio is based in Stockholm, Stockholm County, Sweden.
- How much did AnaCardio raise?
- AnaCardio raised SEK150 Million in a Funding Round round on September 7, 2022.
- What does AnaCardio do?
- AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
- Where is AnaCardio based and how big is it?
- AnaCardio is based in Stockholm, Stockholm County, Sweden. Fundz records about 27 employees.
- Who are the decision-makers at AnaCardio?
- Fundz holds 1 contact at AnaCardio, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Software and Health Care around the same time
Companies in the same sectors as AnaCardio that raised within 45 days of this round, from Fundz verified event records.
- Kyros raised an undisclosed amount (Seed) on October 19, 2022.
- NeuroFlow raised $25M on October 13, 2022.
- Automation Anywhere, Inc. raised $200M (Funding Round) on October 3, 2022.
- Kahun raised $8M (Funding Round) on September 29, 2022.
- Optellum raised $14M (Series A) on September 27, 2022.
- DocSpera raised $10M (Funding Round) on September 27, 2022.
Who to call at AnaCardio, and when
A new round usually means AnaCardio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AnaCardio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AnaCardio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AnaCardio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AnaCardio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AnaCardio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.